HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Heat Biologics, Inc. (HTBX)
0.9046  0.0597  (7.07%) 07-07 14:36
Open: 0.84 High: 0.9558
Pre.close: 0.8449 Low: 0.825
Volume: 12,540,497 Ave vol: 9,555,412
52w High: 1.25 52w Low: 0.2
MA(50): 0.828 MA(200): 0.565
EPS: -0.524 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.heatbio.com
Market Cap (M): 77
Shares Out (M): 85
Heat Biologics, Inc., a biopharmaceutical company, focuses on developing immunotherapies to activate patient's immune system against cancer through T-cell activation and expansion. The company's T-cell activation platform, includes two variations for intradermal administration, such as immune pan-antigen cytotoxic therapy, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and combination pan-antigen cytotoxic therapy, a dual-acting immunotherapy, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. It is developing HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer.
Technical analysis
Overall: Outperform
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 1.37 Target 2: 1.60
Resist 1: 1.17 Resist 2: 1.37
Support 1: 0.88 Support 2: 0.70
Company key metrics
Revenue per Share: 0.0916
Net Income per Share: -0.6015
Cash per Share: 0.2716
Book Value per Share: 0.4078
Price to Sales: 2.7288
Price to Book Value: 0.6131
Earnings Yield: -2.4058
Dividend Yield: 0
Debt to Equity: 0.9126
Debt to Assets: 0.4771
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts
Headline news
Mon, 06 Jul 2020
Growth Curve Analysis: Heat Biologics, Inc. (HTBX) grow 4.48% in last 30 days - The News Heater

Sat, 20 Jun 2020
Newsflash: Heat Biologics, Inc. (NASDAQ:HTBX) Analysts Have Been Trimming Their Revenue Forecasts - Yahoo Finance

Mon, 06 Jul 2020
Heat Biologics Inc (NASDAQ:HTBX PTX-35) Administers PTX-35 To The First Patient At Its First Clinical Trial Site - BP Journal

Thu, 25 Jun 2020
A Lesson to Learn: Heat Biologics, Inc. (HTBX) Jump 1.59% - The News Heater

Fri, 26 Jun 2020
Heat Biologics Inc. (HTBX) went up 0.39% yesterday: Is this the Most Sought-After Stock Today? - News Daemon

Mon, 08 Jun 2020
Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35 - Yahoo Finance

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.